Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer

[1]  Roland Eils,et al.  Tagmentation-based whole-genome bisulfite sequencing , 2013, Nature Protocols.

[2]  Roland Eils,et al.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.

[3]  Jiri Bartek,et al.  Replication stress links structural and numerical cancer chromosomal instability , 2013, Nature.

[4]  S. De,et al.  DNA replication timing and higher-order nuclear organization determine single nucleotide substitution patterns in cancer genomes , 2013, Nature Communications.

[5]  V. Beneš,et al.  Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. , 2013, Cancer cell.

[6]  Replication stress links structural and numerical cancer chromosomal instability (vol 494, pg 492, 2013) , 2013 .

[7]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[8]  Scott L. Pomeroy,et al.  Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.

[9]  J. Denburg,et al.  The LINA cohort: indoor chemical exposure, circulating eosinophil/basophil (Eo/B) progenitors and early life skin manifestations , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[11]  B. Schuster-Böckler,et al.  Chromatin organization is a major influence on regional mutation rates in human cancer cells , 2012, Nature.

[12]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[13]  J. Gribnau,et al.  X chromosome inactivation in the cycle of life , 2012, Development.

[14]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[15]  Andrew C. Adey,et al.  Ultra-low-input, tagmentation-based whole-genome bisulfite sequencing , 2012, Genome research.

[16]  D. Zwijnenburg,et al.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.

[17]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[18]  Alan Hodgkinson,et al.  Variation in the mutation rate across mammalian genomes , 2011, Nature Reviews Genetics.

[19]  Kristian Cibulskis,et al.  Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.

[20]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[21]  B. Kerem,et al.  Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development , 2011, Cell.

[22]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[23]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[24]  Michael O Dorschner,et al.  Sequencing newly replicated DNA reveals widespread plasticity in human replication timing , 2009, Proceedings of the National Academy of Sciences.

[25]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[26]  E. Heard,et al.  X inactivation and the complexities of silencing a sex chromosome. , 2009, Current opinion in cell biology.

[27]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[28]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[29]  J. Stamatoyannopoulos,et al.  Human mutation rate associated with DNA replication timing , 2009, Nature Genetics.

[30]  S. Dimitrov,et al.  Weak but Uniform Enrichment of the Histone Variant macroH2A1 along the Inactive X Chromosome , 2008, Molecular and Cellular Biology.

[31]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[32]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[33]  J. Bartek,et al.  Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis. , 2006, Cancer research.

[34]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[35]  H. Ellegren,et al.  Mutation rate variation in the mammalian genome. , 2003, Current opinion in genetics & development.

[36]  Bruce T Lahn,et al.  Genic mutation rates in mammals: local similarity, chromosomal heterogeneity, and X-versus-autosome disparity. , 2003, Molecular biology and evolution.

[37]  F. Netter,et al.  Supplemental References , 2002, We Came Naked and Barefoot.

[38]  Dmitri A. Nusinow,et al.  Xist RNA and the mechanism of X chromosome inactivation. , 2002, Annual review of genetics.

[39]  T. Canfield,et al.  Role of late replication timing in the silencing of X-linked genes. , 1996, Human molecular genetics.

[40]  Carolyn J. Brown,et al.  The human XIST gene: Analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus , 1992, Cell.

[41]  J. H. Taylor,et al.  Asynchronous duplication of human chromosomes and the origin of sex chromatin. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Lyon.  Gene Action in the X-chromosome of the Mouse (Mus musculus L.) , 1961, Nature.